Aliva Pharmaceuticals' Series A Round

Aliva Pharmaceuticals raised a round of funding on January 25, 2010.

Aliva Biopharmaceuticals, Inc. is building the next generation animal systems for accurate prediction in human drug profiling at the pre-clinical stage with its BAC (Bacterial Artificial Chromosome) b…

Articles about Aliva Pharmaceuticals' Series A Round: